Literature DB >> 2852398

The development of a laboratory model for onchocerciasis using Onchocerca gutturosa: in vitro culture, collagenase effects, drug studies and cryopreservation.

S Townson1.   

Abstract

A range of culture conditions were examined to optimize parasite maintenance. Using male worms in a cell-free system, good results were obtained with medium NCTC 135 + 10% inactivated calf serum (IFCS) in an atmosphere of 95% N2/5% CO2 (median survival time 45 days). Survival was increased to 6-7 months using medium MEM + 10% IFCS + LLCMK2 (monkey kidney) feeder cells in a gas phase of 5% CO2 in air. Worms exposed to collagenase solution (5 mg/ml) were subsequently less motile and survived shorter periods compared to unexposed controls. The drug responses of worms (in vitro) were examined using 13 antiparasitic compounds. Ivermectin and CGP 6140 were among the most active, with the majority of drugs significantly affecting motility levels at a concentration of 5 x 10(-5) M or less. This system may provide useful information on the intrinsic activity of new compounds. A technique was developed for the successful cryopreservation of males in liquid nitrogen using ethanediol as a cryoprotectant in a 2-step incubation procedure, thereby enabling the long-term storage and transportation of worms. In conclusion, the common bovine parasite O. gutturosa provides a practical alternative for research in the absence of O. volvulus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852398

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  5 in total

Review 1.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.

Authors:  K L Goa; D McTavish; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

2.  Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro.

Authors:  Simon Townson; Senyo Tagboto; Helen F McGarry; Gillian L Egerton; Mark J Taylor
Journal:  Filaria J       Date:  2006-03-24

3.  A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.

Authors:  Alice Halliday; Ana F Guimaraes; Hayley E Tyrer; Haelly Mejane Metuge; Chounna Ndongmo Winston Patrick; Kengne-Ouafo Jonas Arnaud; Tayong Dizzle Bita Kwenti; George Forsbrook; Andrew Steven; Darren Cook; Peter Enyong; Samuel Wanji; Mark J Taylor; Joseph D Turner
Journal:  Parasit Vectors       Date:  2014-10-24       Impact factor: 3.876

4.  Successful long-term maintenance of Mansonella perstans in an in vitro culture system.

Authors:  Abdel Jelil Njouendou; Manuel Ritter; Winston Patrick Chounna Ndongmo; Chi Anizette Kien; Gandjui Tchamatchoua Victor Narcisse; Fanny Fri Fombad; Dizzle Bita Tayong; Kenneth Pfarr; Laura E Layland; Achim Hoerauf; Samuel Wanji
Journal:  Parasit Vectors       Date:  2017-11-10       Impact factor: 3.876

Review 5.  Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections.

Authors:  Malina A Bakowski; Case W McNamara
Journal:  Trop Med Infect Dis       Date:  2019-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.